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ABSTRACT:Binding affinity towards DNA for small molecules such as derivatives of Hydroxamic 
acids is very important in the development of new therapeuticreagents The binding interaction of N-
(o-chloro) phenyl benzoh ydroxamicacid (N-(o-chloro)PBHA) with Ct-DNA was measured by four 
methods, (i) UV absorption, (ii) fluorescence emission, (iii) viscosity and (iv)molecular docking. It 
showed that N-(o-chloro) PBHA-DNA complex has less absorption intensity than compound only. 
Significant enhancement of fluorescence intensity was observed for the N-(o-chloro) PBHA-DNA 
complex. The values of binding constant, Kb, is 7.87x 10
-3 
and Stern Volmer constant Ksv is 3.0x10
-3
 
ng
-1μl were obtained by UV absorption and fluorescence spectral methods, respectively. The binding 
interaction trend was further confirmed by viscosity on–Ct-DNA complex which shows the increase 
in viscosity. The molecular docking of N-(o-chloro) PBHA with the DNA showed the groove binding 
nature. This observation further confirmed and supplemented the experimental results. The study 
revealed that the hydroxamic acid derivative seems to have promising anti-cancer drug like nature. 
 
Keywords: Hydroxamic acid, Binding constant, Ct-DNA, Fluorescence, Viscosity, Molecular 
docking. 
 
1. INTRODUCTION 
 
Significant progress has been made over the past few years in studies of drug-DNA 
interactions (Rama Pande et al., 2014). The studies on molecular interaction have great 
importance and become an active research area in recent years. Recently, there has 
been extreme interest in studies related to the interaction between Drug-DNA, because of 
their relevance in the development of new reagents for biotechnology and medicine 
(Manish Pardhi et al., 2016). 
 
Understanding how drugs interact with DNA is of outmost importance as 
researchers struggle to design more efficient and specifically targeted therapeutics, with 
fewer side effects (Tamara Topala et al., 2014). 
 
Over the past decade Hydroxamic acids have attracted considerable attention due to their 
pharmacological, toxicological and pathological properties (Rama Pande et al, 2014). 
They contain a pharmacophoric structural part (-NOH. C=O) (Rita Kakkar, 2013) and 
Hydrogen Bond Donor (HBD) and Hydrogen Bond Acceptor (HBA), capability to bind with 
receptors (Agrawal et al., 1999 and Fazary et al., 2001). Derivatives of N-arylhydroxamic 
acids have also been proved as antitumor/cancer and antioxidant agents. 
DNA is the material of inheritance and control the structure and function of cells, which is 
the major target of most antitumor drugs, as well as many antiviral and antibacterial 
agents. The possible interaction model between small molecules and DNA generally as 
follow: (i) electrostatic binding between cation species and negative charge DNA 
phosphate (ii) groove binding in which molecule bounded in groove of DNA involving 
hydrogen bonding, Vander Waals interaction force (SaherAfshan et al., 2005) and (iii) 
intercalative binding involves between drug and base pairs (Kashanian et al., 2010).  
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Many techniques have been applied for investigation of the interaction of DNA with small 
molecules including UV-Visible Spectrophotometer, fluorescence, CD spectroscopy, X-
ray diffraction, Gel electrophoresis and hydrodynamic measurement. The docking is 
important in the study of various properties associated with protein‐ligand interactions 
such as binding energy and geometry complementarily viscosity (Rama Pande et al., 
2012; Deepeshkhare and Rama Pande, 2012). 
 
In this study, both experimental and computational techniques were used to explore the 
interaction between the N-(o-chloro)phenylbenzohydroxamic acid and DNA.  
 
2.  MATERIALS AND METHODS 
 
2.1 Apparatus 
 
The absorption spectra were measured on Genesys 10S UV-Vis spectrophotometer 
using a 1.0 cm quartz cells. Fluorescence spectra were performed with F-2700 FL 
spectrophotometer, equipped with a xenon flash lamp using a 1.0 cm quartz cell. 
Viscosity measurements were carried out using a thermo stated Ostwald viscometer 
and flow time was measured with a digital stop watch. 
 
2.2 Reagents 
The preparation of N-(o-chloro)phenylbenzohydroxamic acid was done by the 
standard procedure. The purity of synthesized compounds was ascertained by 
determining their melting point, elementary and IR analysis. Value for M.P, N-(o-
chloro)PBHA observed 1120 C and reported 1120 C. 
 
Calf thymus DNA (Sigma Aldrich chem, Co. USA) was used without further 
purification, and its stock solution was prepared by dissolving an appropriate amount 
of DNA into distilled water. pH of buffer solutions was adjusted with 0.01 M HCl to 7.4 
which was prepared by standard procedure. All chemicals were of analytical 
reagents. The stock solution of 500 ng/μl N-(o-chloro)PBHA was dissolved in DMSO. 
 
2.3 UV Spectroscopic Method 
 
The UV spectra of N-(o-chloro)PBHA and DNA- N-(o-chloro)PBHA complex were 
measured in the wavelength range of 200- 350 nm. The binding interaction studies 
were carried out by keeping the fixed concentration of compound (50 ng/μl) to which 
increasing concentration of DNA stock solution (25 ng/μl- 125 ng/μl) was added. The 
intrinsic binding constant of the complex N-(o-chloro)PBHA-DNA was calculated from 
equation,  
 
[DNA]/(εa- εf)  = [DNA]/ (εb- εf ) +  1/Kb(εb- εf )  
 
where, [DNA] is base pair concentration, εb , εf are apparent absorption coefficients 
for bounded and free DNA .Kb the ratio of slope to intercept  was obtained from a plot 
of [DNA] ]/(εb- εf)  versus [DNA],    a slope 1/ ]/(εa- εf)  and an intercept  1/ Kb(εb- εf ). 
 
2.4 Fluorescence Spectroscopic Method 
 
The fluorescence emission spectra were measured in the wavelength range of 320- 
500 nm upon excitation wavelength at 300 nm using slit with 5 nm each. The 
fluorescence titrations were performed by keeping the concentration of N-(o-
chloro)PBHA  constant (50 ng/μl) and varying DNA concentrations (25 ng/μl- 125 
ng/μl). A quantitative estimation of fluorescence studies in terms of the Stern-Volmer 
constant calculation is obtained from Stern Volmer equation, 
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    Fo/F   = 1+ Ksv [Q]  
 
Where,  Ksv - Stern Volmer Constant , Q- Concentration of DNA, F0- Fluorescence 
intensity in absence of DNA and F -Fluorescence intensity in presence of DNA. 
 
2.5       Viscosity method 
 
The viscosity measurements performed at 250 C. A mixture of 15 ml (1.0 ml DNA 
solution in 14.0 ml Tris-HCl Buffer) was taken in viscometer and flow time read to 
kept constant DNA concentration (50 ng/μl). An appropriate amount of N-(o-
chloro)PBHA added at certain r= [HA]/[DNA] and flow time was measured. The data 
were presented as (η/η0)
1/3 versus r, where η and η0 are the viscosity of DNA in the 
presence and absence of the compounds respectively. 
 
2.6  Molecular Docking 
 
The parameters used for the docking process via HEX 6.3 docking Software were, 
 
 • Correlation type – Shape only  
• FFT Mode – 3D   
• Grid Dimension – 0.6  
• Receptor range – 180  
• Ligand Range – 180  
• Twist range – 360 
 • Distance Range – 40 
 
Ligand was drawn and optimized from Gaussian (G09) and converted into PDB file 
using Avogadro. The DNA duplex receptor structure was obtained from Protein Data 
Bank ( PDB. No: ID1BNA) with 12 base pairs DNA sequence 
(CpGpCpGpApApTpTpCpGpCpG) running in 3’- 5’ directions. 
 
3. RESULTS AND DISCUSSION 
 
Change in absorbance and position of band enabled to observe the possible binding 
mode of ct-DNA with the compound for calculating the binding constant. Fig. 1 shows 
the UV absorption of N-(o-chloro)PBHA and DNA-N-(o-chloro)PBHA complex. In the 
absence of DNA because of π-π* excitation state in N-(o-chloro)PBHA (Manish 
Pardhi et al., 2016)., it showed a significant absorption peak, situated at 300 nm.  
When the compound bound to DNA, the intensity was sharply decreasing with hypo-
chromic shift. This evidence confirmed binding of N-(o-chloro)PBHA with DNA. The 
value of Intrinsic binding Kb= 7.87x 10
-3 was obtained for N-(o-chloro)PBHA. 
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Figure 1. Absorption spectra of N-(o-chloro)PBHA in tris-HCl Buffer in the presence and 
absence of ct-DNA. N-(o-chloro)PBHA(50 ng/μl); ct-DNA(25-125 ng/μl) 
 
 
 
 
Figure 2. Plot of [DNA]/Ɛb-Ɛf versus [DNA] for N-(o-chloro)phenylbenzohydroxamic) 
 
N-(o-chloro)PBHA exhibits emission spectra in tris- HCl at pH 7.4 buffer solution at 
ambient temperature with maximum appearing at 341.5 nm (λex= 300 nm). The result 
of fluorescence emission titration for N-(o-chloro)PBHA- DNA were illustrated in Fig 
3. The fluorescence of N-(o-chloro)PBHA efficiently enhanced upon binding to DNA 
and increasing concentration of DNA resulted increase in the fluorescence intensity 
of N-(o-chloro)PBHA. Thus it was concluded that molecules have been interacted 
with DNA. In N-(o-chloro)PBHA, presence of chlorine enhances the quenching of 
emission spectra due to additional intramolecular hydrogen-bond with hydroxyl 
hydrogen. 
The value of Ksvis 3.0x10-3 ng-1μl for N-(o-chloro)PBHA -DNA complex have been 
obtained from the plot between Fo/F vs Q as shown in the figure 4. 
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Figure 3. Fluorescence emission spectra of N-(o-chloro)PBHA(50 ng/μl) with increasing amount 
of DNA(25-125 ng/μl) 
 
 
Figure 4. Stern - Volmer plot of N-(o-chloro)PBHA with increasing concentration of DNA 
 
The interaction between PBHA and DNA were further confirmed via viscometric studies. 
In general, intercalation caused an increase in the viscosity of DNA solution as due to 
lengthening of DNA helix as the base pair are pushed apart (Manish Pardhi et al., 2016 
and Bharati Verma et al., 2014). It can be seen from the Figure 5, a typical relative DNA 
viscosity increased with increasing concentration of N-(o-chloro)PBHA. This may be 
due to the intercalative mode of interaction of compound with DNA. 
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    Figure 5. Effect of increasing concentration of N-(o-chloro)PBHA on relative viscosity of DNA. 
 
The structure of the N-(o-chloro)PBHA- DNA complex was predicted from the docking 
studies using Hex 6.3 software. The structure was studied for various inter-molecular 
interactions and later subjected to Energy analysis of the complexes. The Etotal energy 
obtained -179.33 eV for N-(o-chloro)PBHA- DNA complex (Fig. 7).The Docked 
Structure act likeN-(o-chloro)PBHAbinds at the minor groove of DNA double helix as 
shown in Fig 6. 
 
   
Figure 6. Docked structure of N-(o-chloro)PBHA- DNA complex. 
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Figure 7. Hex molecular docking shows Etotal to be -179.33 eV . 
 
 
4.  CONCLUSION 
  
The binding interaction between N-(o-chloro)PBHA and ct-DNA was investigated using 
UV absorption, fluorescence, viscosity and molecular docking methods. Experimental 
results indicated that the binding strength of the complexes with ct-DNA exhibited the Kb 
Value of 7.87x 10-3 and  Ksv value of 3.0x10-3 ng-1μl in in UV absorption and 
fluorescence emissions respectively. The high binding constants in both experiments 
showed strong affinity of binding interaction of N-(o-chloro)PBHA with DNA. This may be 
due to the groove mode of binding while having significant enhancement of fluorescence 
intensity and linear increase in relative viscosity. Results of molecular docking 
supplemented and validated the experimental results. This investigation will throw light in 
the understanding of anti-cancer, anti-tumor and other medicinal properties of derivatives 
of N-arylhydroxamic acids (N-(o-chloro)PBHA) at the molecular level. The knowledge 
gained from this study has opened a window for understanding the pharmacological 
effects of N-(o-chloro)PBHA as a possible and promising drug. 
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